| P2093 | author name string | Regis J O'Keefe | |
| | Edward M Schwarz | |
| | Lisa M Flick | |
| | Xinping Zhang | |
| | Michael Ulrich-Vinther | |
| | William C Dougall | |
| | Jason M Weaver | |
| | Dirk Anderson | |
| | Faruk Abuzzahab | |
| P2860 | cites work | Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation | Q24311588 |
| | Osteoprotegerin: a novel secreted protein involved in the regulation of bone density | Q24313918 |
| | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function | Q24336057 |
| | RANK is essential for osteoclast and lymph node development | Q24598872 |
| | MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes | Q24628843 |
| | Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand | Q24653311 |
| | Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL | Q24682139 |
| | Bone resorption by osteoclasts | Q28145169 |
| | In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis | Q28216662 |
| | OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis | Q28589430 |
| | The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. | Q33823576 |
| | RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 |
| | Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene | Q37265676 |
| | The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts. | Q41649459 |
| | Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. | Q42505465 |
| | The effect of a single dose of osteoprotegerin in postmenopausal women | Q43520860 |
| | Nonunion of the femoral diaphysis. The influence of reaming and non-steroidal anti-inflammatory drugs. | Q52863756 |
| | Osteopetrosis, a New Recessive Skeletal Mutation on Chromosome 12 of the Mouse | Q67444875 |
| | Production of a standard closed fracture in laboratory animal bone | Q70651275 |
| | A standardized experimental fracture in the mouse tibia | Q70682553 |
| | Effect of nonsteroidal antiinflammatory drugs on fracture healing: a laboratory study in rats | Q70827122 |
| | Effect of alendronate on fracture healing and bone remodeling in dogs | Q71049971 |
| | Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats | Q73069669 |
| | Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord | Q73766127 |
| | Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats | Q77823078 |
| | Skeletal Renewal and Metabolic Bone Disease | Q93757957 |
| | Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model | Q93937216 |
| P433 | issue | 4 | |
| P304 | page(s) | 676-684 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | Journal of Orthopaedic Research | Q6295700 |
| P1476 | title | Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing | |
| P478 | volume | 21 | |